These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 4194907

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Muscle in Lafora disease.
    Coleman DL, Gambetti P, Mauro SD, Blume RE.
    Arch Neurol; 1974 Dec; 31(6):396-406. PubMed ID: 4140718
    [No Abstract] [Full Text] [Related]

  • 25. [Histochemical studies on myoclonus bodies in progressive myoclonus epilepsy (Unverricht type)].
    Schnabel R, Seitelberger F.
    Acta Neuropathol; 1969 Sep 09; 14(1):19-37. PubMed ID: 4186140
    [No Abstract] [Full Text] [Related]

  • 26. Progressive myoclonus epilepsy without Lafora bodies.
    Matthews WB, Howell DA, Stevens DL.
    J Neurol Neurosurg Psychiatry; 1969 Apr 09; 32(2):116-22. PubMed ID: 5783287
    [No Abstract] [Full Text] [Related]

  • 27. [Central nervous system deposits in protractive (Lundborg-type myoclonic bodies disease].
    Jakob H.
    Acta Neuropathol; 1969 Apr 09; 12(3):260-75. PubMed ID: 5792203
    [No Abstract] [Full Text] [Related]

  • 28. Myoclonus epilepsy with Lafora bodies: case report with electron microscopic observation.
    Jenis EH, Schochet SS, Earle KM.
    Mil Med; 1970 Feb 09; 135(2):116-9. PubMed ID: 4991175
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Progressive myoclonus epilepsy with Lafora inclusion bodies. I. Clinical, genetic, histopathologic, and biochemical aspects.
    Janeway R, Ravens JR, Pearce LA, Odor DL, Suzuki K.
    Arch Neurol; 1967 Jun 09; 16(6):565-82. PubMed ID: 6026066
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Progressive malignant myoclonic epilepsy (Lafora's disease). Clinical and biochemical study of a case].
    Rallo E, Martin F, Infante F, Beaumanoir A, Klein D.
    Acta Neurol Psychiatr Belg; 1968 May 09; 68(5):356-69. PubMed ID: 4237172
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Autopsy findings on Lafora's disease with special reference to the electron-microscopic findings of the Lafora body and chemical analysis of the brain].
    Hashi N, Yamada T, Mimura M, Wake R, Nakata K.
    Seishin Shinkeigaku Zasshi; 1969 Feb 09; 71(2):140-52. PubMed ID: 5814367
    [No Abstract] [Full Text] [Related]

  • 38. [Diagnosis and treatment of Unverricht-Lundborg type progressive myoclonic epilepsy].
    Declerck A.
    Acta Neurol Psychiatr Belg; 1968 Jul 09; 68(7):471-82. PubMed ID: 4974923
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.